(Q34616438)

3 August 2017

1 reference

title

Acute bacterial meningitis in infants and children. (English)

1 reference

3 August 2017

1 reference

1 reference

Kwang Sik Kim

1

1 reference

3 August 2017

publication date

1 January 2010

1 reference

Lancet Infectious Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

10

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

32-42

1 reference

Predicting the outcome of neonatal bacterial meningitis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Long term outcome of neonatal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Bacterial meningitis in infants: the epidemiology, clinical features, and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Influence of admission findings on death and neurological outcome from childhood bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

The cell biology of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Invasion of brain microvascular endothelial cells by group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Outer membrane protein A and cytotoxic necrotizing factor-1 use diverse signaling mechanisms for Escherichia coli K1 invasion of human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

CD46 in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Clinical isolates of measles virus use CD46 as a cellular receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

CD46 is a cellular receptor for group B adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Escherichia coli outer membrane protein A adheres to human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Identification and characterization of an Escherichia coli invasion gene locus, ibeB, required for penetration of brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

The gene locus yijP contributes to Escherichia coli K1 invasion of brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Invasion of the central nervous system by intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Listeria monocytogenes-infected bone marrow myeloid cells promote bacterial invasion of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Treatment strategies for central nervous system infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Involvement of focal adhesion kinase in Escherichia coli invasion of human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

RhoA and Rac1 contribute to type III group B streptococcal invasion of human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Differential role of cytosolic phospholipase A2 in the invasion of brain microvascular endothelial cells by Escherichia coli and Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Improving the outcome of neonatal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Diseases that mimic meningitis. Analysis of 650 lumbar punctures

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Signs of meningeal irritation at the emergency department: how often bacterial meningitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Bacterial counts in cerebrospinal fluid of children with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Laboratory diagnosis of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Detection of bacterial antigens in body fluids by the Phadebact system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Gram stain-specific-probe-based real-time PCR for diagnosis and discrimination of bacterial neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Loop-mediated isothermal amplification method targeting the lytA gene for detection of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Nucleic acid isothermal amplification technologies: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Rapid diagnosis of bacterial meningitis using a microarray

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Sensitivity of the Bacterial Meningitis Score in 889 Children with Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Practice guidelines for the management of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Antimicrobial agents in the treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

First molecular characterization of group B streptococci with reduced penicillin susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Treatment failure in meningococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Meningococcal meningitis during penicillin therapy for meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Moxifloxacin in the therapy of experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Gemifloxacin is effective in experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Systemic quinolone antibiotics in children: a review of the use and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Corticosteroids for acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Association between persistence of pneumococcal meningitis and dexamethasone administration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970306-8

7 January 2021

10.1016/S1473-3099(09)70306-8

Identifiers

DOI

1 reference

3 August 2017

1 reference